Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P06889 (
Mol
)
630,302
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
1. The renal response to aldosterone (urinary sodium and
potassium
excretion) was determined in adrenalectomized rats previously fed either a high
potassium
diet or a control diet. High K+ rats showed an enhanced response to aldosterone at all doses tested. 2. This enhanced response to aldosterone required the presence of the adrenal glands during the induction period, could be suppressed by a high sodium intake, but could not be induced by a low sodium diet. 3. No difference between high K+ and control rats could be detected in renal mineralcorticoid receptors, assessed by both in vivo and in vitro binding of tritiated aldosterone. 4. The method of the induction, and the mechanism of the enhanced response, remain to be defined.
Clin Sci
Mol
Med Suppl 1976 Dec
PMID:Increased renal sensitivity to aldosterone in the potassium-loaded rat. 107 35
1. The effect of long-term treatment with prindolol on blood pressure, total body
potassium
(Kt), exchangeable sodium (Nae) and plasma renin activity was investigated in twelve patients with essential hypertension. 2. Systolic and diastolic pressures were significantly reduced from 164/112 to 127/90 mmHg under basal conditions. 3. Before treatment Nae in patients with essential hypertension was significantly higher than in normotensive individuals. After an average of 16 weeks on prindolol Nae in patients with essential hypertension was significantly decreased, despite an average increased in body weight of 2 kg in the patients. 4. In contrast to the decrease in Nae, Kt was found to be significantly increased after long-term treatment with prindolol. Kt values of patients before and after prindolol, however, did not differ significantly from the corresponding sex- and age-dependent normal values. 5. Plasma renin activity was slightly diminished under basal and orthostatic conditions; the stimulatory effect orthostatis was not abolished but reduced by prindolol. 6. It is suggested that the changes in sodium balance contribute to the anti-hypertensive effect of prindolol in patients with essential hypertension.
Clin Sci
Mol
Med Suppl 1976 Dec
PMID:Increase of total body potassium and decrease of exchangeable sodium after long-term treatment with a beta-receptor-blocking agent (prindolol) in essential hypertension. 107 79
1. Isolated hind limbs of rats were perfused and vascular smooth muscle sensitivity to noradrenaline, methoxamine and
potassium
chloride was measured and dose-response curves were obtained. 2. The sensitivity of vascular smooth muscle to noradrenaline is attenuated by adrenalectomy and low sodium diet; it is enhanced by corticosterone. High sodium diet or administration of deoxycorticosterone did not alter the dose-response curve significantly. 3. The increased sensitivity of vascular smooth muscle after corticosterone treatment is not related to changes in the contractile protein or alterations in the neuronal uptake and extraneuronal metabolism of noradrenaline. 4. These results suggest that the increased sensitivity in corticosterone-treated rats may be due to the number of receptors, receptor affinity to noradrenaline, or changes in the functional link between receptor and contractile apparatus.
Clin Sci
Mol
Med Suppl 1976 Dec
PMID:Changes in vascular smooth muscle sensitivity to vasoconstrictor agents induced by corticosteroids, adrenalectomy and differing salt intake in rats. 107 90
1. A cross-over study was done in twenty patients with hypertension to compare the effects of chlorothiazide (0-5 g twice daily) and metolazone (5 mg daily) in combination with other anti-hypertensive agents. 2. Compared with absence of diuretic therapy, chlorothiazide and metolazone both produced significantly lower blood pressures. 3. Blood pressures on metolazone tended to be lower than on chlorothiazide but this difference was not statistically significant. 4. Both diuretics significantly lowered serum
potassium
concentrations and total body
potassium
to a similar degree, but the serum
potassium
did not fall below the normal range in any patient and no
potassium
supplements were needed. No electrocardiographic changes suggestive of hypokalaemia were noted. 5. Small but significant increases in serum bicarbonate, calcium, urea and acid were observed with both diuretics. 6. Patient acceptance was excellent and no adverse effects were encountered.
Clin Sci
Mol
Med Suppl 1976 Dec
PMID:A comparison of the effects of chlorothiazide and of metolazone in the treatment of hypertension. 107 94
1. The mechanism by which pretreatment of rats with intracisternal 6-hydroxydopamine prevents the onset of deoxycorticosterone hypertension has been studied. 2. Rats pretreated with central 6-hydroxydopamine increase their consumption of 0-17 mol/l sodium chloride--0-03 mol/l
potassium
chloride ('saline') less than normal rats when implanted with deoxycorticosterone. 3. Intact rats restricted to the equivalent consumption of saline of rats pretreated with 6-hydroxydopamine develop hypertension despite this restriction. 4. It is suggested that the prevention of deoxycorticosterone hypertension by central 6-hydroxydopamine does not depend on reduced saline consumption.
Clin Sci
Mol
Med 1975 Apr
PMID:Role of saline consumption in the prevention of deoxycorticosterone hypertension in rats by central 6-hydroxydopamine. 112 24
1. Total body
potassium
was estimated by 40-K measurement with a high-sensitivity whole body counter in normal individuals over a wide age range and in patients who were obese or were grossly wasted as a result of various conditions which restricted food intake. 2. Potassal males and females, but when individuals of different age groups were matched for height, a significant fall in total body
potassium
with increasing age was observed only in males. Total body
potassium
of females was about 75% that of males of similar height when young, the sex difference decreasing with ageing. In the normal population, total body
potassium
was significantly correlated with height and with weight; regression equations for various relationships are given. 3. Fat-free mass was estimated from total body
potassium
, values of 65 and 56 mmol of
potassium
/kg fat-free mass being used for males and females respectively. Body fat estimated by this method correlated well with skinfold measurements over a wide range of body weight but in malnourished individuals having inadequate food intake there was considerable fat-free mass from total body
potassium
appear unsatisfactory in malnutrition. Considerable differences between expected and observed values of total body
potassium
were found in muscular individuals and in normal individuals who were thin but whose body weight was relatively constant. 4. The patients with malnutrition were low both in body fat as estimated by skinfold thcikness and in total body
potassium
estimated on the basis of height. Plasma
potassium
was, however, normal and
potassium
supplements did not increase the total body
potassium
. 5. Total body
potassium
of obese individuals was not significantly different from that of normal weight individuals on the basis of height. Total body
potassium
fell on weight reduction with a very low energy diet of 1260 kJ (300 kcal.) daily but changed little with a 3300 kJ (800 KCAY POTASSIUM WAS BEST PREDICTED FROM THE INDIVIDUAL'S HEIGHT. For those whose body weight was less than expected, the use of weight gave the best prediction but the error was considerable when the weight deviation was large.
Clin Sci
Mol
Med 1975 May
PMID:Total body potassium and body fat estimation in relationship to height, sex, age, malnutrition and obesity. 112 34
1. A technique is described for the measurement of
potassium
and water spaces in less than 1 mul of packed cells. 2. The total
potassium
content of cell pellets is measured in a perchloric and nitric acid extract by flame spectrophotometry. The
potassium
in trapped medium is estimated from the distribution space of hydroxy[-14C]methylinulin and subtracted from the total
potassium
content to give intracellular
potassium
content. Corticosterone output was measured by radioimmunoassay. 3. The simultaneous measurement of total water from the [-3H]water space allows calculation of the intracellular water space. 4. Values obtained for intracellular
potassium
content, intracellular water space and calculated intracellular
potassium
concentration are presented for different preparations of isolated adrenal cortical cells.
Clin Sci
Mol
Med 1975 Jul
PMID:Micromethods for the simultaneous measurement of intracellular potassium and corticosterone output of isolated adrenal cortical cells. 114 91
1. Serial measurements of serum potasssium and total-body
potassium
were made on eighteen patients with megaloblastic anaemia before the start of therapy and during the period of recovery. 2. In those patients who presented with an initial packed cell volume of less than 25%, a mean decrease in serum
potassium
of 0.4 mmol/1 occurred on average with 2.5 days of the start of therapy. This was followed by a significant increase in serum
potassium
during the period of recovery. There was a significant increase in total-body
potassium
in these patients, but this could be explained by increases in erythrocyte mass, erythrocyte
potassium
concentration and lean body mass.
Clin Sci
Mol
Med 1975 Jul
PMID:Potassium changes in megaloblastic anaemia. 114 98
1. Total body
potassium
was measured, by wholebody counting, in children with coeliac disease and in children not having this disease, matched as closely as possible with respect to sex, height, weight and age. 2. The measured total body
potassium
in children with coeliac disease was not significantly different from that in the matched children. 3. The problems associated with such measurements, particularly those of interpretation, are considered.
Clin Sci
Mol
Med 1975 Aug
PMID:Total body potassium in children, with particular reference to coeliac disease. 114 4
A ribonucleoprotein was released from carefully purified rat liver mitochondrial polyribosomes after dissociation with 1 M
potassium
chloridepuromycin. This ribonucleoprotein was characterized by a sedimentation coefficient ranging from 10-14 S and buoyant density of 1.48 g cm(-3) in cesium chloride equilibrium centrifugation differing in these parameters from the subunits of mitochondrial ribosomes. Poly(A)-containing RNA constituted more than 30% of the total RNA content in this non-ribosomal ribonucleoprotein.
Mol
Biol Rep 1975 Jul
PMID:Messenger RNA-containing ribonucleoprotein from mitochondrial polyribosomes of rat liver. 116 Aug 79
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>